---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "kSqa3l+BkJCm1ujK1QpSvetR40S6DsIekqskh9Irg1e7+3ZMAER23heH8ruhwBsPLehtumq2pdSYn6Qs4FboWHbEofHu7L+/TLvpTKuLM6L2UFAnAGaN+4cIgZGfi2OOoOkR+ugqeDPMepj7+jnJ4rTaGuKdXEFLfrXcO6fUHRlyizFszWdn3UjuEITL+DNWpI2Wmkj2EyLYruB1NkS4s8J/G0s7ZGtZFsLumWhbOQd88MovwkDWfPT44KjwA6NOE9sY+aKqJSjWKYIFDz2iTaeV7SPmXfhBgMZAdn9ojt59rRNW0pyHinflNaZ5TaulS8gCKkNMGKIpv47nZOtR4Ehup+1EbiTgJt86dQ5vfC4=;qRhpvYUJ0MQ8kAGQWk+yFA=="
---

